Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), $1.06, +0.15, 16.48%, has been trading in a range today from 0.87 to 1.14 with gains of over 16%.  Sunesis reported that it had granted Carmot Therapeutics an exclusive license to its proprietary Fragment-Based Lead Discovery (FBLD) technology.  Sunesis retains full rights to the technology for use in its future internal discovery efforts. Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. 

Tethys Petroleum Limited (TSX: TPL), $1.78, -0.04, -2.20%, was trading in the 0.90’s in January and today is seeing its trading in the range of 1.72 and 2.04 surging past 1.47 which was the previous 52 week-high from February 9^th.  Tethys announced the initial results of its testing on the upper zone oil discovery in Kazakhstan.  The discovery showed a restricted rate of over 5,400 barrels per day.  Together with the testing done on the lower zone the AKD01 flowed oil over 6,800 barrels per day.  Tethys Petroleum is an oil and gas exploration and production company focusing in Central Asia with activities in the Republic of Kazakhstan and the Republic of Tajikistan.

Sierra Minerals Inc. (TSX: SIM), $0.34, +0.04, 13.33%, is a gold producer focused on acquiring and developing advanced stage gold deposits that have the likelihood of realizing near-term production.  Sierra announced that it has entered into a binding Letter Agreement with Goldgroup Resources, a privately-held British Columbia company.  The goal of the combination is to create a premier junior gold production company mainly focused in Mexico.  Sierra Minerals has been trading in the range of 0.30 and 0.34 coming close to touching on its 52 week-high of 0.39 from mid January. 

Samson Oil & Gas Limited (AMEX: SSN), $0.425, +0.068, 19.08%, is focuses on exploration and development of oil and natural gas properties in the United States.  All five of Samson’s material oil and gas properties are producing properties.  Samson reported on their drilling results at the Bakken Formation citing that recorded gas shows are consistent and oil shows are continuous with improvement.  The company reported that “common greenish brown oil was observed at the shale shakers.” Samson has been trading in the range of 0.373 and 0.44 today with considerable gains of over 20%.  The 52 week-high sits at 1.09 from last September.

Opko Health Inc. (AMEX: OPK), $1.98, +0.04, 2.06%, is trading on gains today hitting the day’s high of 2.05 with a low of 1.94.  The 52 week-high sits at 2.91 from last September.  Opko is a healthcare company set on discovery development and commercialization of proprietary pharmaceuticals for treatment of ophthalmic diseases and conditions.  Opko announced that it has developed a simple diagnostic blood test for Alzheimer’s disease.  Opko`s test which was designed to detect increased levels of antibodies special to Alzheimer’s disease, was around 95% accurate in its initial testing.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Compugen Ltd.  (NASDAQ:CGEN) rose 7.07% up to $ 4.39 on news the company posted narrower losses than expected in their 2009 Q4 results. During the last quarter of 2009 the company benefitted from a partnership with Pfizer to develop their pipeline, and successfully raised capital to further fund discoveries in 2010.  The company made progress and received promising results from studies of in vivo trails for various treatment candidates for cancer and inflammation.  Based in Tel Aviv, Israel, Compugen is a drug company which discovers and commercializes its candidates by early-stage licensing and co-development deals. The company’s business is focused on developing and using predictive computer-based discovery platforms to determine therapeutic drug candidates and diagnostic biomarker candidates. GCEN stock has gained 698% since last February.

Oncolytics Biotech, Inc. (TSE:ONC) jumped 14.95% up to $3.23 on no news; however the company is expected to begin enrolment for its upcoming Phase 3 trial for Reolysin.  Reolysin is being developed as a therapeutic for the treatment of head and neck cancers.  Headquartered in Calgary, Alberta, Oncolytics Biotech, Inc is a biopharmaceutical company which discovers and develops therapeutic products for the treatment of cancer.  The company currently has more than a dozen trials at various stages in the US, UK and Canada for their lead drug candidate Reolysin. The company has a market cap of about $183 million and the financial wherewithal to fund the company through Phase 3 FDA evaluations.  According to Research and Markets the global head and neck cancer market is expected to grow at a rate of 8.3% annually for the next six years to reach $1,809M by 2016.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Western Coal Corp. (TSX: WTN), $3.43, +0.28, 8.89%, is making considerable gains today trading near the day’s high of 3.47 touching down on a low of 3.26.  Western Coal released its operating results for the three and nine month period ending December 31, 2009.  Some key points included consolidated revenues of $118.7 million were 10% higher than fiscal second quarter 2010, attributable to 175,000 tonnes of coal sold at previous coal year prices.  Western Coal also reports that they commenced operations on a permit for Maple Coal surface mine which increases reserves of marketable tons to over 10 million short tons, which is a 67% increase in the Maple surface reserves.  Western is a producer of high quality metallurgical and thermal coal from mines located in northeast British Columbia and West Virginia.

Arco Resources Corp. (TSXV: ARR), $0.06, +0.015, 33.33%, is trading in a tight spread between 0.045 and 0.07, coming close to reaching its 52 week-high of 0.075.  The company holds a 100% interest in six mineral claim blocks in Oaxaca, Mexico.  Arco reported on its underground sampling program from its 386 hectare Taviche property.  The results showed a 230 metre long shoot of the vein with silver-gold values averaging 173 g/t silver (Ag) and 1.5 g/t gold (Au).  Other samplings identified a similar 220 metre long shoot averaging 161 g/t Ag and 2.18 g/t Au.  The Tavish vein is a silver-gold-bearing quartz vein.

Rexahn Pharmaceuticals Inc. (AMEX: RNN), $0.76, +0.07, 10.14%, is a clinical stage pharmaceutical company focused on treatments of cancer, CNS disorders, sexual dysfunction and other medical needs.  The company has three drug candidates in Phase II clinical trials, Archexin™, Serdaxin™ and Zoraxel™.  RNN has been trading today between the 0.68 and 0.825 range on gains of over 10%.  Rexahn is presenting today at the 12th Annual BIO CEO & Investor Conference.  Rexhan’s Chairman and CEO, Dr. Chang H. Ahn, will speak about a business overview and provide updates on Rexahn’s recent clinical and financing milestones.

Cord Blood America Inc. (OTCBB: CBAI), $0.01, +0.001, 11.11%, is trading the day away in the range of 0.009 and 0.011, with the 52 week-high sitting at 0.02.  Cord Blood announced yesterday that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc.  BioCells is the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD) and 12 locations throughout that country.  Cord Blood America facilitates umbilical cord blood stem cell preservation for expectant parents and their children.

Cell Therapeutics Inc. (NASDAQ: CTIC), $0.78, +0.14, 21.88%, focuses on the development, acquisition and commercialization of drugs for the treatment of cancer.  On February 11, 2010, the Cell Therapeutic’s team will host a conference call to review the Company’s 2009 fourth quarter and year-end achievements and financial results.  Cell Therapeutics is trading between 0.74 and 0.80, with its 52 week-high sitting at 2.23.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Kingsway Financial Services Inc. (TSX: KFS), $1.84, +0.32, 21.05%, is trading in the range of 1.72 and 2.07 with heavier than usual volume on news that it has entered into a definitive purchase agreement with The Westaim Corporation where Kingsway will sell all of the issued and outstanding shares of Jevco Insurance Company to Westaim, for approximate purchase of 94.5% of the book value of Jevco as at December 31, 2009.  Kingsway Financial is involved in the non standard automobile insurance in North America.

GenVec Inc. (NASDAQ: GNVC), $3.10, +0.11, 3.68%, has been on a steady rise in the last months and is trading the day away between 2.96 and 3.34, with gains of 3.68%.  The company is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec’s product, TNFerade™ is currently in a pivotal clinical study in locally advanced pancreatic cancer.  GNVC announced that its trial in esophageal cancer was presented at the American Society of Clinical Oncology’s 2010 Gastrointestinal Cancer Symposium.  GenVec also announced that the company has entered into a research collaboration and license agreement. GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders.

Brookemount Capital Inc. (TSXV: BKT), $0.105, +0.025, 31.25%, announced that it has entered into negotiations on a contiguous block of land in direct vicinity of the recent lithium discovery made by First Gold Exploration Inc.  A final decision on this property is anticipated to be completed in the in the coming days.  Brookemount has been trading in the range of 0.095 and 0.125 with gains of 37.50%.  Brookemont currently has 96 mineral claims prospective for lithium covering an area of approximately 3,800 acres located in Northern Ontario, 93 load quartz mineral claims covering an area of approximately 4,836 acres, located in the Yukon, bordering Underworld Resources Inc and now 6,687 acres in the Stewart Gold District of British Columbia

Rentech Inc. (AMEX: RTK), $1.23, +0.03, 2.50%, announced that along with ClearFuels Technology it has been awarded  a conditional $22.6 million grant from the U.S. Department of Energy for its project to construct a biomass gasifier at Rentech’s Energy Technology Center.  The gasifier will be integrated with Rentech’s Product Demonstration Unit for the production of renewable synthetic fuels from biomass.  RTK has been steady trading between the 1.23 and 1.32 range.  Rentech, incorporated in 1981, provides clean energy solutions.

Alix Resources Corp. (TSXV: AIX), $0.08, +0.005, 6.67%, is heavily trading today on the TSX Venture between 0.08 and 0.10.  AIX announced that it has entered into an agreement to acquire a 100% interest in ground applied for adjacent to First Gold Exploration Pivert/Rose Property. Terms of the deal call for Alix to pay the vendor a total of $50,000 and 2 million shares of the company on claim application approval and TSX Venture approval.  Alix Resources is a junior exploration company focusing on mineral and energy opportunities.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

PicksThatMove.com Announces Investment Opinion on Kingsway Financial Services Inc., GenVec Inc., Brookemount Capital Inc., Rentech Inc. and Alix Resources Corp.

NOTE TO EDITORS:  The investment opinions offered below and in this press release are provided by Nick Hunter, RIA, of Picksthatmove.com.

CALGARY, Alberta–(BUSINESS WIRE)–PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation. These companies have interesting business models and they have to execute on the business development level to bring value to shareholders. Some of our past picks had soared over 200%. To view some of our profiled stocks, please visit our website at www.picksthatmove.com.

At PicksThatMove, our team scours the technical and financials of hundreds of companies to identify those stocks showing the greatest potential for growth.

Kingsway Financial Services Inc. (TSX: KFS), $1.84, +0.32, 21.05%, is trading in the range of 1.72 and 2.07 with heavier then usual volume on news that it has entered into a definitive purchase agreement with The Westaim Corporation where Kingsway will sell all of the issued and outstanding shares of Jevco Insurance Company to Westaim, for approximate purchase of 94.5% of the book value of Jevco as at December 31, 2009.  Kingsway Financial is involved in the non standard automobile insurance in North America.

GenVec Inc. (NASDAQ: GNVC), $3.10, +0.11, 3.68%, has been on a steady rise in the last months and is trading the day away between 2.96 and 3.34, with gains of 3.68%.  The company is a biopharmaceutical company developing novel therapeutic drugs and vaccines. GenVec’s product, TNFerade™ is currently in a pivotal clinical study in locally advanced pancreatic cancer.  GNVC announced that its trial in esophageal cancer was presented at the American Society of Clinical Oncology’s 2010 Gastrointestinal Cancer Symposium.  GenVec also announced that the company has entered into a research collaboration and license agreement. GenVec and Novartis will collaborate to discover and develop novel treatments for hearing loss and balance disorders.

Brookemount Capital Inc. (TSXV: BKT), $0.105, +0.025, 31.25%, announced that it has entered into negotiations on a contiguous block of land in direct vicinity of the recent lithium discovery made by First Gold Exploration Inc.  A final decision on this property is anticipated to be completed in the in the coming days.  Brookemount has been trading in the range of 0.095 and 0.125 with gains of 37.50%.  Brookemont currently has 96 mineral claims prospective for lithium covering an area of approximately 3,800 acres located in Northern Ontario, 93 load quartz mineral claims covering an area of approximately 4,836 acres, located in the Yukon, bordering Underworld Resources Inc and now 6,687 acres in the Stewart Gold District of British Columbia

Rentech Inc. (AMEX: RTK), $1.23, +0.03, 2.50%, announced that along with ClearFuels Technology it has been awarded  a conditional $22.6 million grant from the U.S. Department of Energy for its project to construct a biomass gasifier at Rentech’s Energy Technology Center.  The gasifier will be integrated with Rentech’s Product Demonstration Unit for the production of renewable synthetic fuels from biomass.  RTK has been steady trading between the 1.23 and 1.32 range.  Rentech, incorporated in 1981, provides clean energy solutions.

Alix Resources Corp. (TSXV: AIX), $0.08, +0.005, 6.67%, is heavily trading today on the TSX Venture between 0.08 and 0.10.  AIX announced that it has entered into an agreement to acquire a 100% interest in ground applied for adjacent to First Gold Exploration Pivert/Rose Property. Terms of the deal call for Alix to pay the vendor a total of $50,000 and 2 million shares of the company on claim application approval and TSX Venture approval.  Alix Resources is a junior exploration company focusing on mineral and energy opportunities.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Poniard Pharmaceuticals Inc. (NASDAQ: PARD), $2.61, +0.47, 21.96%, traded the day away between 2.17 and 2.70, closing on gains of 21.96%.  Poniard Pharmaceuticals is a biopharmaceutical company with its main focus on the development and commercialization of cancer therapy products.  Poniard works with picoplatin as a preferred platinum agent in the treatment of solid tumor malignancies.  The company listed its targets for 2010 for Picoplatin as completing discussions with the FDA for a regulatory path forward for picoplatin, among others.

Vantage Drilling Co. (AMEX: VTG), $1.58, +0.09, 6.04%, announced that it has priced its public offering of 30,000,000 of its ordinary shares at $1.49 per share. Closing is expected on January 27, 2010.  Underwriters have an option exercisable for 30 days to purchase additional 4,500,000 ordinary shares.  Gross proceeds are approximately $44.7 million. Company intends to use proceeds for working capital and general corporate purposes.  Vantage offers contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells.

Uranium One Inc. (TSX : UUU), $3.39, +0.08, 2.42%, has made gains today and traded in the range of 3.31 to 3.52.  If things continue UUU could surpass its 52 week high of 4.07 from May of last year.  Uranium announced record results for the fourth quarter and for the 2009 year.  The success is a result of an increase in production at the South Inkai Uranium Mine. UUU also reported on the completion of its C$270 million convertible debenture financing with the JUMI consortium and the receipt of a US$20 million dividend from its Betpak Dala JV.  Uranium One is the world’s largest publicly traded uranium producers, with portfolio of assets in Kazakhstan, the United States, South Africa and Australia.

On2 Technologies Inc. (AMEX: ONT), $0.694, -0.028, -3.93%, traded today between 0.72 and 0.69.  The company closed the day with a loss of 3.93%.  ONT has been trying to get past the mid 0.70’s for over a week now.  The company announced earlier that they will be amending the merger agreement wherein Google will acquire On2.  Each outstanding share of On2 common stock will receive 0.0010 of Google Class A Common Share plus an additional $0.15 per share in cash consideration.  On2 is a developer of video compression technology and technology for enabling multimedia in resource-limited environments such as battery operated mobile handsets.

Vital Products Inc. (OTCBB: VTPI), $0.007, 0.0003, 4.48%, made progress today of 4.48% in their share price.  This is significant gain for VTPI in a considerable amount of time on heavy volume.  The company announced that it has completed preliminary discussions with a multi national sealant company.  Vital has been in talks with this company for 6 months and is developing environmental bio-based “foam in a can” to be used for residential construction and Do It Yourself markets.   Vital Products is a distributor of industrial packaging products.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

La Jolla Pharmaceutical Co. (NASDAQ: LJPC), $0.229, +0.029, 14.36%, is making gains today trading in the range of 0.264 and 0.21 with higher than usual volume on no news.  The last company announcement released this past December advised of La Jolla’s filing for a proposed merger with Adamis Pharmaceuticals Corporation.  Adamis stockholders holding approximately 35% of the outstanding common stock of Adamis have agreed to vote in favour of the merger, which is expected to close by the end of first quarter of 2010.  La Jolla is Biopharmaceutical Company focusing on research and development of therapeutic products for treatment of life-threatening antibody-mediated diseases.

Ambient Corporation (OTCBB: ABTG), $0.16, +0.025, 18.52%, is making strong gains today trading steadily between 0.20 and 0.15 with a surge in volume on news.  The company reports that along with Verizon Wireless it has launched a jointly developed Open Smart Grid Communications Architecture, which is an integrated smart grid solution and open communications network for utilities deploying smart grid programs.  Ambient Corporation is an integrator of smart grid communications platforms, creating high-speed Internet Protocols-based data communications networks over existing distribution grids.

Alcoa Inc. (NYSE: AA), $15.83, +0.31, 2.00%, is in the business of production and management of primary aluminum, fabricated aluminum, and alumina combined.  The company is making gains today, trading steadily in the range of 15.41 and 15.90.  The company posted fourth quarter 2010 net income loss of $277 million, or $0.28 per share, which is much less compared to the same quarter last year with a loss of $1.19 billion, or $1.49 a share. The company cites net charges for restructuring, special items and tax items that total $275 million.

UAL Corp. (NASDAQ: UAUA), $13.77, +1.08, 8.51%, is active today hitting a high of 14.00, which is not far from its 52 week-high of 14.10 which was reached at the beginning of January.  Earlier this month United Airlines, which is a wholly owned subsidiary of UAL Corporation, announced that it priced two offerings of secured debt securities totalling $700 million, consisting of $500 million aggregate principal amount of 9.875% senior secured notes due 2013 and $200 million aggregate principal amount of 12.000% senior second lien notes due 2013.

MedeFile International Inc. (OTCBB: MDFI), $0.018, +0.007, 63.22%, is trading the day between 0.02 and 0.012 on significant volume.  The last company announcement from December reported on the signing of an agreement with Caring People, Inc. to provide memberships for Caring People’s clients in need of homecare. Caring People has purchased an initial 300 memberships.  MedeFile is a leader in portable electronic medical records management.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Icagen, Inc. (NASDAQ:ICGN) advanced 44.93% up to $1.00 on news the company’s executive management is participating at the 28th Annual JP Morgan Healthcare Conference this week at the Westin St. Francis Hotel in San Francisco.  Management is scheduled to present an overview of its research and development programs at 11:30 a.m. Pacific Time on Thursday, January 14th. The company currently has clinical stage programs for two drug candidates for the treatment of epilepsy, asthma, and inflammation and pain control. Based in Research Triangle Park, North Carolina, Icagen, Inc. is a biopharmaceutical company committed to the discovery, development and commercialization small molecule drugs.     

CombinatoRx, Incorporated (NASDAQ:CRXX) rose 23.44% up to $1.00 at midday on no news, since the company announced changes to its senior management team following its merger with Neuromed.  The company expects news on February 22nd from the FDA regarding a review of the New Drug Application for Neuromed’s drug candidate Exalgo for pain management.  Based in Cambridge, Massachusetts, CombinatoRx, Inc., is a biopharmaceutical company which discovers, develops, and out-licenses combination pharmaceuticals created by blending drugs to treat various diseases, cancer, metabolic diseases, inherited diseases, and other medical conditions.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) soared 34.26% up to $1.45 on no news with 22,170,136 shares trading actively at midday. The company has gained 244% over the last thirty days.  Recently SNSS regained compliance with the NASDAQ after its shares dropped below the $1 level for an extended period.  The company disclosed promising developments at the end of 2009: a Phase 2 Voreloxin study for leukemia proved that patients who dosed Voreloxin combined with chemotherapy had an increased survival rate. Patients with acute myeloid leukemia usually live for only about three to six months. Headquartered in South San Francisco, California, Sunesis Pharmaceuticals, Inc is a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for hematologic and solid tumour cancers. Its primary product candidate is Voreloxin, an anticancer treatment is in Phase 2 development stage.   

Adeona Pharmaceuticals Inc. (AMEX:AEN) jumped 24.69% up to $1.06 on no news with 5,821,823 shares trading hands at midday. Based in Ann Arbor, Michigan, Adeona Pharmaceuticals Inc is a development-stage pharmaceutical company conducting awareness campaigns and advancing the diagnosis, prevention, and treatment of zinc deficiency and chronic copper toxicity in the aging population.  The company is developing late-stage drug candidates for rheumatoid arthritis and multiple sclerosis.  The company is also developing Trimesta, an anti-inflammatory estrogen agent in Phase 2 clinical trials for the treatment of post-menopausal hot flashes; and Oral Flupirtine, a non-opiate non-addictive oral therapy for the treatment of fibromyalgia and other ophthalmic indications.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Breakwater Resources Ltd. (TSX: BWR), $0.50, +0.05, 11.11%, surged in volume today with gains of over 11%, surpassing its 52 week-high to 0.50, on no news. BWR last announced that it entered into royalty agreements with Red Mile Resources No. 15 Limited Partnership and Ronpam Resources Limited Partnership where Breakwater sold basic royalties on a portion of the payable zinc production, over the life of the Myra Falls mine. Breakwater received cash of $69.4 million, which included royalty income of $62.6 million and fees and interest of $6.8 million.  Breakwater is a mineral resource company mainly focused in the Americas.

Largo Resources (TSXV: LGO), $0.215, +0.06, 38.71%, is involved in the import and export business of frozen food and general merchandise to Asian countries. LGO made considerable gains today matching its 52 week-high from last October of 0.22, touching down on the day’s low of 0.1555, considerably surpassing its average volume mark.  Byron Capital Markets has initiated coverage on Largo Resources with a Buy rating and a target price of $0.95.

Ford Motor Company (NYSE: F), $11.37, +0.41, 3.74%, surpassed its 52 week-high from yesterday touching on a new high today of 11.46.  Ford Motor, a car and truck producer, reported that the GT is back.  The Mustang GT is powered by an all-new engine - with a legendary 5.0 liter displacement - featuring Twin Independent Variable Camshaft Timing and aluminum block and heads.  The 2011 Mustang GT has 412 horsepower and 390 ft-lb. of torque with highway fuel economy of 25 mpg.

Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), $1.34, +0.26, 24.07%, closed the day up slightly over 24%, touching on the day’s high of 1.62 with a low of 1.09.  This past December SNSS hit

 its 52 week-high of 2.43.  Prior to last year end SNSS announced that it regained compliance with the minimum $1.00 per share bid price requirement. Under NASDAQ’s Listing Rules, to regain compliance, the Company was required to evidence a closing bid price of $1.00 per share or more for at least ten consecutive days. Sunesis is biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics for oncology.  

Advaxis Inc. (OTCBB: ADXS), $0.133, +0.005, 3.91%, made slight gains today on above average volume, reaching the day’s high of 0.15.  Advaxis is a biotechnology company utilizing multiple mechanisms of immunity with the intent to develop cancer vaccines that are more effective and safer than existing vaccines.  Advaxis reports that it has been granted and will be issued the European patent for its Listeria vector. This is in addition to the US and Japan approvals for this technology and extends Advaxis’ intellectual property protection.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) slid -3.55% to $1.36 on news yesterday the FDA declined the company’s insomnia drug Silenor for the second time this year; the stock has slide more than 50% since Friday’s close.  The clinical safety of the drug was not an issue for the FDA; however the government agency said the drug candidate did not meet their efficacy standard for sustained subjective sleep required to maintain effectiveness in adults with insomnia.  The next move for the company will be to meet with the FDA for specific guidance to conduct additional clinical work. Undaunted, the company is currently consulting with its clinical and regulatory advisors and will push forward to seek approval and commercialization of the drug candidate.

Last month Somaxon reported that its cash and cash equivalents of $5.4 million as of September 30^th, would be sufficient to finance its operations through the FDA’s review of Silenor and through the second quarter of 2010; and as of September 30^th the company had no debt.  Headquartered in San Diego, California, Somaxon is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the central nervous system such as insomnia.  Despite the worst of the recession and FDA setbacks, SOMX stock has gained 27% since December 2008.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter